HHS OIG`s most important policy initiative in 2018 — its new fraud risk indicator and the public identification of companies that have refused to enter into CIAs if the OIG believes a CIA is necessary — continued to draw Congressional attention to how the agency sets up its exclusion agencies and other authorities responsible for program enforcement and integrity. While the pace of new CIA news decreased slightly compared to 2017, HHS OIG continued to focus on provisions that impose integrity monitoring obligations at the highest levels of the company, including within the board of directors, and on strengthening the separation of compliance and legal and other functions. The roundtable entitled “Focus on Compliance – The Next Generation of Corporate Integrity Agreements” should receive information on compliance “best practices” and efforts to implement a working method that is in line with the law and effective in accordance with the terms of a CIA. . . .